Date(s) - Wed 23. Sep 2020
10:00 - 11:30
Kategorien Keine Kategorien
Entering China’s Healthcare Market?
Learn from those who do it successfully!
The Greater Bay Area Healthcare Seminar Series offers you and your company first-hand experience from those who are operating their business in China already today and those who have been involved in foreign healthcare companies entering the Chinese market successfully. Learn from success stories, participate in case studies, and exchange or communicate with experts in China:
10:00-10:05: Opening & Welcome (Mr. Peter Helis)
10:05-10:15: News & Updates from Huangpu Healthcare Cluster
(Mr. Li Ling – tbc)
10:15-10:45: Success Story from Huangpu – RichardsonBio
(Mrs. Lucy Xu; www.richardsonbio.cn)
10:45-11:15: Case Study from Munich –
(Dr. Moritz Völker-Albert; https://www.epiqmax.com/)
11:15-11:30: Q&A (Mr. Peter Helis)
The seminar concept at a glance
(SME) Success Stories: Foreign companies that entered the Chinese market successfully. What were the challenges they faced? What lessons did they learn? Which solutions did they find? How did they proceed and execute? What are they planning next?
(SME) Case Studies: Foreign companies that are planning to enter the Chinese market – presenting their business model, technologies and (strategic) considerations regarding China. Furthermore, our healthcare industry experts in China will present market and competition analysis, business model, financing and supportive measure possibilities and regulatory affairs aspects as well as details on recommended approaches and necessary processes for each presented case study.
Exchange with Experts: Our seminars are designed as online & offline events, which gives you the opportunity to interact with the presented companies as well as our experts in China (e.g. business developers, distributors, regulatory affairs specialists, government officials).
Located at the heart of Greater Bay Area (GBA) Huangpu is one of the TOP 3 high tech and future economy development zones in China. More than 60,000 companies (~20,000 foreign invested companies), including 200 Fortune 500 companies successfully operate in Huangpu. Therefore also the “Huangpu Healthcare Hub” is one of the most developed healthcare clusters in China, housing BeiGene Biologic’s large molecules manufacturing site (a US $330 million investment) as well as many other healthcare giants such as Innocare, Lonza, GE LifeSciences, Zeiss or Akeso. And also the number of international start-ups and SMEs entering the Chinese market at our location is growing strongly in recent years.